NEXR (NEXR) Stock Price & Analysis
NEXR (NEXR) fell 13.55% to USD 0.8 as of June 10, 2026 at 00:46 UTC, according to Nexqual real-time market data.
NEXR last closed at USD 0.93; the session ranged USD 0.8–0.9 on volume of 1,715,201 shares. Market capitalization is $1.42M, with a 52-week range of USD 0.8–149.94 (NCM). Source: Nexqual, June 10, 2026 at 00:46 UTC.
Key Statistics (as of June 10, 2026 at 00:46 UTC)
| Price | USD 0.8 |
|---|---|
| Change | ▼ 13.55% (down) |
| Previous Close | USD 0.93 |
| Open | USD 0.86 |
| Day Range | USD 0.8 – 0.9 |
| 52-Week Range | USD 0.8 – 149.94 |
| Volume | 1,715,201 shares |
| Market Cap | $1.42M |
| Exchange | NCM |
Technical Analysis (NEXR)
Nexqual's technical model rates NEXR "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.79 (neutral) |
| vs SMA50 | Below (USD 1.71) |
| MACD | -0.24 (negative) |
Analyst Ratings (NEXR)
Wall Street analysts rate NEXR "None", per Nexqual as of June 10, 2026 at 00:46 UTC.
| Consensus Rating | None |
|---|
Earnings (NEXR)
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financials & Fundamentals (NEXR)
| Total Revenue | $16.83M |
|---|---|
| Revenue Growth (YoY) | +31.50% |
| Gross Margin | +10.55% |
| Operating Margin | -41.56% |
| Profit Margin | -21.85% |
| ROE | -44.93% |
| Debt / Equity | 45.43 |
| Current Ratio | 1.82 |
| Total Cash | $1.64M |
| Total Debt | $5.66M |
| Free Cash Flow | $-2.95M |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financial Health Score (NEXR)
Nexqual rates NEXR's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:46 UTC.
| Growth | Strong — Revenue +32% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $2M cash vs $6M debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -45%, ROA -26.4% |
Ownership (NEXR)
| Insider Ownership | +0.11% |
|---|---|
| Institutional Ownership | +0.04% |
| Shares Outstanding | 1.77M |
| Float | 800,980 |
| Short % of Float | +49.16% |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Leadership (NEXR)
NEXR is led by Eliyahu Zamir (age 55), Chief Executive Officer, per Nexqual as of June 10, 2026 at 00:46 UTC.
| Chief Executive Officer | Eliyahu Zamir (age 55) |
|---|---|
| Chief Financial Officer | Ronen Zalayet (age 56) |
| Chief Operating Officer | Naor Bergman (age 34) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMND | Clearmind Medicine Inc. | USD 3.39 | ▼ 14.82% |
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
| AKAN | Akanda Corp. | USD 13.76 | ▼ 11.96% |
| BDRX | Biodexa Pharmaceuticals plc | USD 3.1 | ▼ 7.74% |
| SOBR | SOBR Safe, Inc. | USD 0.75 | ▼ 26.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:46 UTC. This page is informational and not investment advice.